Genmab — September 2015
-
Du har helt ret bulder
-
Man kan forestille sig det meste, men ved opkøb bliver dine aktier typisk købt til overkurs. Ved fusion får du aktier i det nye selskab. Som hovedregel
-
Lidt fra den anden side af dammen: http://blogs.barrons.com/stockstowatchtoday/2015/09/24/biotech-two-charts-that-scream-sell/?mod=yahoobarrons&ru=yahoo
-
-
Nu er det 3 uger siden vi fik priority review, 78 dage siden full submission og 112 dage siden rolling submission startede...
-
var den en BLA eller en sBLA?
-
Har mange møder i dag. Dejligt at komme til pause og se, at kursen er steget hver gang.
-
-
nice
-
Det er ikke noget man ser hver dag
-
jeg kan se, at det vist er Opdivo fra BMS, der holder rekorden for hurtig godkendelse
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind